Bhagwati P Kabra

This inventor holds 27 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Alcon Research, Ltd., Alcon Laboratories, Inc., Alcon, Inc.. Active years: 1997-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bhagwati P Kabra. Retrieved from https://idiyas.com/inventor/bhagwati-p-kabra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 9)

% Patents Active = 81.5

CIPO Patents = 7

EPO Patents = 15 (Patent Applications = 17)

Average Co-Inventor Count = 1.5

ph-index = 7

Forward Citations = 204(Granted Patents)

Location History:

Fort Worth, TX (US) (1997 - 1998)
Arlington, TX (US) (2001 - 2012)
Euless, TX (US) (2010 - 2017)

Company Filing History:

Alcon Laboratories, Inc.

Alcon Manufacturing, Ltd.

Years Active: 1997-2017

Loading Chart...

Areas of Expertise:

Pharmaceutical Suspension

Aqueous Compositions

Bioavailability

Ophthalmic Compositions

Drug Delivery

Self-Preserved Formulations

Fluoroquinolone Antibiotics

Thermally-Gelling Emulsions

Intravitreal Injection

Receptor Tyrosine Kinase Inhibitors

Topical Ophthalmic Drugs

Non-Polymeric Implants

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9707173 - Pharmaceutical suspension (2017-07-18),

2. 9504691 - Finafloxacin suspension compositions (2016-11-29),

3. 9421265 - Aqueous pharmaceutical compositions containing borate-polyol complexes (2016-08-23),

4. 9144561 - Pharmaceutical compositions having desirable bioavailability (2015-09-29),

5. 9044484 - Aqueous pharmaceutical compositions containing borate-polyol complexes (2015-06-02),

6. 8912236 - Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye (2014-12-16),

7. 8785497 - Aqueous ophthalmic compositions containing anionic therapeutic agents (2014-07-22),

8. 8754123 - Pharmaceutical compositions having desirable bioavailability (2014-06-17),

9. 8722735 - Pharmaceutical compositions having desirable bioavailability (2014-05-13),

10. 8469934 - Pulsatile peri-corneal drug delivery device (2013-06-25),

11. 8450287 - Topical ophthalmic compositions containing tobramycin and dexamethasone (2013-05-28),

12. 8323630 - Self-preserved aqueous pharmaceutical compositions (2012-12-04),

13. 8268299 - Self preserved aqueous pharmaceutical compositions (2012-09-18),

14. 8211880 - Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection (2012-07-03),

15. 8178582 - Pharmaceutical compositions having desirable bioavailability (2012-05-15),

Title: The Innovative Journey of Inventor Bhagwati P Kabra

Introduction:

Bhagwati P Kabra, a talented inventor based in Euless, TX (US), has made significant contributions to the field of innovations with his creative mindset and dedication to problem-solving.

Latest Patents:

Bhagwati P Kabra holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to existing challenges.

Career Highlights:

Throughout his career, Bhagwati P Kabra has demonstrated a keen eye for identifying gaps in the market and developing groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations:

Bhagwati P Kabra has collaborated with leading companies, research institutions, and universities to further enhance his inventions and bring them to the market. His collaborative spirit has allowed him to tap into a wealth of knowledge and expertise, resulting in the development of cutting-edge technologies.

Conclusion:

Inventor Bhagwati P Kabra's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true trailblazer in the world of inventions. His impact on various industries is profound, and his legacy as an inventor continues to inspire future generations to think outside the box.

Profile summary based on public USPTO records.